News

The Komets, along with every other team in the ECHL, announced their season-ending rosters on Monday to begin the process of ...
KOMET is an ongoing phase III trial that randomized ... more than 8 years before enrollment. Chen noted a between-group difference in median tumor volume (92 mL in the selumetinib arm and 222 ...
Fueled by volatile chemicals and raw ambition, the Me 163 Komet was both a technological marvel and a death trap. Pilots ...
The Rapid City Rush announced Monday that Dave Smith has been named the team’s next head coach and general manager, per a ...
FORT WAYNE, Ind. – The Fort Wayne Komets announced their protected list of players submitted to the ECHL following the 2024-25 season. The list of 28 players includes 19 forwards and nine ...
FORT WAYNE, Ind. (WANE) – After earning the ECHL’s Defenseman of the Year honors, Komets blue liner Kyle Mayhew is continuing his hockey career overseas in Germany. The Augsburger Panthers of ...
The number of Komets players from the 2024-25 season that won’t be with the team beginning next season doubled last week and included two of their top skaters. Team captain and last season’s ...
ALL RIGHT BRITTANY THANK YOU. KANSAS CITY MISSOURI RESIDENTS ARE EXPRESSING ALARM AFTER A HATE GROUP MARCHED IN DOWNTOWN KANSAS CITY YESTERDAY. WE GOT FOOTAGE OF THAT GROUP WHILE THEY WERE AT THE ...
By late 2024, the phase 2 KOMET-001 trial had enrolled 112 patients in North America and Europe—all with relapsed/refractory NPM1-mutated AML. Patients received ziftomenib 600 mg orally once a ...